Work

Clinical and Pathological Prognostic Markers for Survival in Adult Patients with Post-Transplant Lymphoproliferative Disorders (PTLD), BCL2 Is a Poor Prognostic Marker in PTLD.

Year: 2006

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v108.11.2035.2035

Authors: Ana B. Oton, Hong Wang, Mona Melhem, Diane George, Irene M. Ghobrial

Institutions: UPMC Hillman Cancer Center, Harvard University, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2563672725

FWCI:

Cites:

Cited by:

Related to: 10